首页 > 最新文献
paperpass

Mass Spectrometry Reviews最新文献

英文 中文
Mass Spectrometry-Based Extracellular Vesicle Proteomics for Biomarker Discovery. 基于质谱的细胞外囊泡蛋白质组学的生物标志物发现。
IF 6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-08-03 DOI: 10.1002/mas.70040
Ya-Juan Liu, Juan Peng, Chao Kang

Extracellular vesicle (EV) proteomics has emerged as a powerful platform for decoding intercellular communication and advancing biomarker discovery across human diseases. EVs carry proteins that reflect their cells of origin, offering a minimally invasive window into physiological and pathological processes. Mass spectrometry (MS) now enables deep, high-resolution EV proteome profiling, aided by improved isolation and rigorous characterization that ensure sample purity and integrity. Advanced computational pipelines integrating quantitative modeling, spectral-library prediction, machine learning and multi-omics analysis extract meaningful biological signals, revealing subtle disease-associated EV signatures and establishing EV proteomics as a strong platform for biomarker discovery and precision medicine. This review provides an integrated framework linking EV isolation principles, characterization strategies, mass-spectrometric workflows, and computational analysis to the biological and clinical insights they generate. We also highlight key challenges and future directions, including the need for standardized reference materials, unified pre-analytical workflows, and EV proteome reference atlases. Together, these innovations are transforming EV proteomics into a next-generation tool for precision medicine.

细胞外囊泡(EV)蛋白质组学已经成为解码细胞间通讯和推进人类疾病生物标志物发现的强大平台。电动汽车携带的蛋白质反映了其起源细胞,为研究其生理和病理过程提供了一个微创窗口。质谱(MS)现在可以实现深度,高分辨率EV蛋白质组分析,辅以改进的隔离和严格的表征,确保样品的纯度和完整性。集成定量建模、光谱库预测、机器学习和多组学分析的先进计算管道提取有意义的生物信号,揭示与疾病相关的细微疾病特征,并将EV蛋白质组学建立为生物标志物发现和精准医学的强大平台。这篇综述提供了一个完整的框架,将EV分离原理、表征策略、质谱工作流程和计算分析与它们产生的生物学和临床见解联系起来。我们还强调了关键的挑战和未来的方向,包括对标准化参考材料、统一的分析前工作流程和EV蛋白质组参考图谱的需求。总之,这些创新正在将EV蛋白质组学转变为下一代精准医疗工具。
{"title":"Mass Spectrometry-Based Extracellular Vesicle Proteomics for Biomarker Discovery.","authors":"Ya-Juan Liu, Juan Peng, Chao Kang","doi":"10.1002/mas.70040","DOIUrl":"https://doi.org/10.1002/mas.70040","url":null,"abstract":"<p><p>Extracellular vesicle (EV) proteomics has emerged as a powerful platform for decoding intercellular communication and advancing biomarker discovery across human diseases. EVs carry proteins that reflect their cells of origin, offering a minimally invasive window into physiological and pathological processes. Mass spectrometry (MS) now enables deep, high-resolution EV proteome profiling, aided by improved isolation and rigorous characterization that ensure sample purity and integrity. Advanced computational pipelines integrating quantitative modeling, spectral-library prediction, machine learning and multi-omics analysis extract meaningful biological signals, revealing subtle disease-associated EV signatures and establishing EV proteomics as a strong platform for biomarker discovery and precision medicine. This review provides an integrated framework linking EV isolation principles, characterization strategies, mass-spectrometric workflows, and computational analysis to the biological and clinical insights they generate. We also highlight key challenges and future directions, including the need for standardized reference materials, unified pre-analytical workflows, and EV proteome reference atlases. Together, these innovations are transforming EV proteomics into a next-generation tool for precision medicine.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Tutorial for Computational Methods of Protein Structure Prediction Incorporating Mass Spectrometry Data. 结合质谱数据的蛋白质结构预测计算方法综合教程。
IF 6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-07-07 DOI: 10.1002/mas.70038
Zachary C Drake, Robert M Bolz, Elijah H Day, Steffen Lindert

Here we present a series of tutorials demonstrating the use of various methods which integrate structural mass spectrometry (MS) data with computational protein structure prediction methods. We give usage examples of widely used modeling frameworks, including Rosetta-based approaches (ab initio modeling, comparative modeling, and protein-protein docking) and deep learning methods such as AlphaFold2. We then describe strategies for incorporating covalent labeling, ion mobility, and surface-induced dissociation MS data into these workflows through Rosetta scoring terms and specialized applications. Finally, we provide instructions on calculating structural metrics, such as solvent accessibility, collision cross sections, and energy-resolved MS data and comparing them to actual MS data. We also introduce new PyRosetta implementations of the PARCS algorithm and the SID_ERMS_Rescore application. Together, these tutorials provide a comprehensive framework for integrating computational modeling with structural MS to enhance protein structure prediction.

在这里,我们提供了一系列的教程,展示了各种方法的使用,这些方法将结构质谱(MS)数据与计算蛋白质结构预测方法相结合。我们给出了广泛使用的建模框架的使用示例,包括基于rosetta的方法(从头开始建模,比较建模和蛋白质-蛋白质对接)和深度学习方法,如AlphaFold2。然后,我们描述了通过Rosetta评分术语和专门应用程序将共价标记、离子迁移率和表面诱导解离MS数据纳入这些工作流程的策略。最后,我们提供了计算结构指标的说明,如溶剂可及性、碰撞截面和能量分辨质谱数据,并将它们与实际的质谱数据进行比较。我们还介绍了PARCS算法的新的PyRosetta实现和SID_ERMS_Rescore应用程序。总之,这些教程提供了一个综合的框架,将计算建模与结构质谱相结合,以增强蛋白质结构预测。
{"title":"Comprehensive Tutorial for Computational Methods of Protein Structure Prediction Incorporating Mass Spectrometry Data.","authors":"Zachary C Drake, Robert M Bolz, Elijah H Day, Steffen Lindert","doi":"10.1002/mas.70038","DOIUrl":"10.1002/mas.70038","url":null,"abstract":"<p><p>Here we present a series of tutorials demonstrating the use of various methods which integrate structural mass spectrometry (MS) data with computational protein structure prediction methods. We give usage examples of widely used modeling frameworks, including Rosetta-based approaches (ab initio modeling, comparative modeling, and protein-protein docking) and deep learning methods such as AlphaFold2. We then describe strategies for incorporating covalent labeling, ion mobility, and surface-induced dissociation MS data into these workflows through Rosetta scoring terms and specialized applications. Finally, we provide instructions on calculating structural metrics, such as solvent accessibility, collision cross sections, and energy-resolved MS data and comparing them to actual MS data. We also introduce new PyRosetta implementations of the PARCS algorithm and the SID_ERMS_Rescore application. Together, these tutorials provide a comprehensive framework for integrating computational modeling with structural MS to enhance protein structure prediction.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13413113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148403007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometry Insights Into Post-Translational Modifications in Extracellular Vesicles. 细胞外囊泡翻译后修饰的质谱分析。
IF 6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-28 DOI: 10.1002/mas.70036
Dávid Virág, Krisztián Márk Karvaly, Alexandra Molnár, Mirjam Balbisi, Júlia Németh, Lilla Turiák

Extracellular vesicles (EVs) are membrane-enclosed structures secreted by virtually all living cells, serving as essential mediators of intercellular communication in both physiological and pathological processes. There is growing interest in their potential applications as biomarkers, therapeutic targets, and drug delivery systems, which entails the need for a detailed understanding of their molecular composition. The functional cargo of EVs includes all types of biological macromolecules, among which proteins are of particular importance. As the vesicular proteome becomes increasingly mapped, research attention is gradually shifting toward post-translational modifications (PTMs), which fundamentally influence protein function and play key roles in all aspects of vesicular activity, including biogenesis, cargo sorting, recognition, and uptake. In this review, we outline recent advances in the application of mass spectrometry (MS)-based analysis of PTMs in EVs. In this context, we provide an overview of the roles of various PTMs in EV biology, discuss the impact of EV isolation methods on downstream PTM analyses, and address current challenges and approaches related to MS-based investigations. We further highlight key findings concerning specific PTMs, including glycosylation, phosphorylation, acetylation, methylation, lipidation, and small ubiquitin-like modifier (SUMOylation). Finally, we discuss studies focusing on the simultaneous analysis of multiple PTMs, as well as efforts toward multiomic data integration and single-EV characterization to resolve vesicular heterogeneity, highlighting these approaches as cutting-edge directions in the field.

细胞外囊泡(EVs)是由几乎所有活细胞分泌的膜封闭结构,在生理和病理过程中都是细胞间通讯的重要介质。人们对它们作为生物标志物、治疗靶点和药物输送系统的潜在应用越来越感兴趣,这就需要详细了解它们的分子组成。电动汽车的功能货物包括各种类型的生物大分子,其中蛋白质尤为重要。随着囊泡蛋白质组的研究越来越深入,研究的重点逐渐转向翻译后修饰(PTMs),它从根本上影响蛋白质的功能,并在囊泡活性的各个方面发挥关键作用,包括生物发生、装载分选、识别和摄取。在这篇综述中,我们概述了基于质谱(MS)分析电动汽车中PTMs的最新进展。在此背景下,我们概述了各种PTM在EV生物学中的作用,讨论了EV分离方法对下游PTM分析的影响,并解决了当前与ms研究相关的挑战和方法。我们进一步强调了关于特定PTMs的关键发现,包括糖基化、磷酸化、乙酰化、甲基化、脂化和小泛素样修饰物(SUMOylation)。最后,我们讨论了多个ptm同时分析的研究,以及多组学数据集成和单ev表征以解决囊泡异质性的努力,强调了这些方法是该领域的前沿方向。
{"title":"Mass Spectrometry Insights Into Post-Translational Modifications in Extracellular Vesicles.","authors":"Dávid Virág, Krisztián Márk Karvaly, Alexandra Molnár, Mirjam Balbisi, Júlia Németh, Lilla Turiák","doi":"10.1002/mas.70036","DOIUrl":"https://doi.org/10.1002/mas.70036","url":null,"abstract":"<p><p>Extracellular vesicles (EVs) are membrane-enclosed structures secreted by virtually all living cells, serving as essential mediators of intercellular communication in both physiological and pathological processes. There is growing interest in their potential applications as biomarkers, therapeutic targets, and drug delivery systems, which entails the need for a detailed understanding of their molecular composition. The functional cargo of EVs includes all types of biological macromolecules, among which proteins are of particular importance. As the vesicular proteome becomes increasingly mapped, research attention is gradually shifting toward post-translational modifications (PTMs), which fundamentally influence protein function and play key roles in all aspects of vesicular activity, including biogenesis, cargo sorting, recognition, and uptake. In this review, we outline recent advances in the application of mass spectrometry (MS)-based analysis of PTMs in EVs. In this context, we provide an overview of the roles of various PTMs in EV biology, discuss the impact of EV isolation methods on downstream PTM analyses, and address current challenges and approaches related to MS-based investigations. We further highlight key findings concerning specific PTMs, including glycosylation, phosphorylation, acetylation, methylation, lipidation, and small ubiquitin-like modifier (SUMOylation). Finally, we discuss studies focusing on the simultaneous analysis of multiple PTMs, as well as efforts toward multiomic data integration and single-EV characterization to resolve vesicular heterogeneity, highlighting these approaches as cutting-edge directions in the field.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148336946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardization Challenges and Breakthroughs in Apolipoprotein B Detection: From Immunoassays to LC-MS/MS. 载脂蛋白B检测的标准化挑战与突破:从免疫分析到LC-MS/MS。
IF 6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-24 DOI: 10.1002/mas.70035
Anqi Pan, Haijian Zhao, Jing Wang, Jiangtao Zhang, Hao Zheng, Chuanbao Zhang, Wenxiang Chen, Tianjiao Zhang

Apolipoprotein B (apoB) is a key biomarker for risk assessment and treatment monitoring of atherosclerotic cardiovascular disease (ASCVD). Its clinical value has been validated by multiple studies, and its predictive performance for ASCVD risk is significantly superior to conventional lipid indicators in populations with complex lipid profiles. However, the standardization of apoB detection has long been a core bottleneck restricting its widespread clinical application, as discrepancies in results between different methods and laboratories can biases in clinical decision-making. In recent years, the development of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) technology has provided a solution for optimizing apoB standardization. Currently, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is promoting the development of a primary reference measurement procedure based on mass spectrometry, aiming to achieve apoB standardization traceable to the International System of Units (SI). This review systematically outlines the clinical value of apoB, main detection methods, standardization challenges, and the application and prospects of LC-MS/MS in overcoming these challenges. We aim to provide insights for further optimizing apoB detection standardization.

载脂蛋白B (apoB)是动脉粥样硬化性心血管疾病(ASCVD)风险评估和治疗监测的关键生物标志物。其临床价值已被多项研究证实,在复杂血脂人群中,其对ASCVD风险的预测性能明显优于传统的血脂指标。然而,载脂蛋白ob检测的标准化一直是制约其广泛临床应用的核心瓶颈,不同方法和实验室之间结果的差异可能会影响临床决策。近年来,液相色谱-串联质谱(LC-MS/MS)技术的发展为优化载脂蛋白ob的标准化提供了解决方案。目前,国际临床化学和检验医学联合会(IFCC)正在推动基于质谱法的初级参考测量程序的发展,旨在实现可追溯至国际单位制(SI)的载脂蛋白ob标准化。本文系统综述了载脂蛋白ob的临床价值、主要检测方法、标准化挑战以及LC-MS/MS在克服这些挑战方面的应用和前景。我们的目标是为进一步优化apoB检测标准化提供见解。
{"title":"Standardization Challenges and Breakthroughs in Apolipoprotein B Detection: From Immunoassays to LC-MS/MS.","authors":"Anqi Pan, Haijian Zhao, Jing Wang, Jiangtao Zhang, Hao Zheng, Chuanbao Zhang, Wenxiang Chen, Tianjiao Zhang","doi":"10.1002/mas.70035","DOIUrl":"https://doi.org/10.1002/mas.70035","url":null,"abstract":"<p><p>Apolipoprotein B (apoB) is a key biomarker for risk assessment and treatment monitoring of atherosclerotic cardiovascular disease (ASCVD). Its clinical value has been validated by multiple studies, and its predictive performance for ASCVD risk is significantly superior to conventional lipid indicators in populations with complex lipid profiles. However, the standardization of apoB detection has long been a core bottleneck restricting its widespread clinical application, as discrepancies in results between different methods and laboratories can biases in clinical decision-making. In recent years, the development of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) technology has provided a solution for optimizing apoB standardization. Currently, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is promoting the development of a primary reference measurement procedure based on mass spectrometry, aiming to achieve apoB standardization traceable to the International System of Units (SI). This review systematically outlines the clinical value of apoB, main detection methods, standardization challenges, and the application and prospects of LC-MS/MS in overcoming these challenges. We aim to provide insights for further optimizing apoB detection standardization.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148306333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometry-Based Proteomics for Assessing Epitranscriptomic Regulations 基于质谱的蛋白质组学用于评估表观转录组法规。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2024-10-18 DOI: 10.1002/mas.21911
Yen-Yu Yang, Zhongwen Cao, Yinsheng Wang

Epitranscriptomics is a rapidly evolving field that explores chemical modifications in RNA and how they contribute to dynamic and reversible regulations of gene expression. These modifications, for example, N6-methyladenosine (m6A), are crucial in various RNA metabolic processes, including splicing, stability, subcellular localization, and translation efficiency of mRNAs. Mass spectrometry-based proteomics has become an indispensable tool in unraveling the complexities of epitranscriptomics, offering high-throughput, precise protein identification, and accurate quantification of differential protein expression. Over the past two decades, advances in mass spectrometry, including the improvement of high-resolution mass spectrometers and innovative sample preparation methods, have allowed researchers to perform in-depth analyses of epitranscriptomic regulations. This review focuses on the applications of bottom-up proteomics in the field of epitranscriptomics, particularly in identifying and quantifying epitranscriptomic reader, writer, and eraser (RWE) proteins and in characterizing their functions, posttranslational modifications, and interactions with other proteins. Together, by leveraging modern proteomics, researchers can gain deep insights into the intricate regulatory networks of RNA modifications, advancing fundamental biology, and fostering potential therapeutic applications.

表转录组学(Epitranscriptomics)是一个快速发展的领域,它探索 RNA 中的化学修饰以及它们如何对基因表达的动态和可逆调控做出贡献。这些修饰(如 N6-甲基腺苷(m6A))在各种 RNA 代谢过程中至关重要,包括 mRNA 的剪接、稳定性、亚细胞定位和翻译效率。基于质谱的蛋白质组学已成为揭示表转录组学复杂性不可或缺的工具,可提供高通量、精确的蛋白质鉴定和差异蛋白质表达的准确定量。在过去二十年里,质谱技术的进步,包括高分辨率质谱仪的改进和创新的样品制备方法,使研究人员能够对表转录组规定进行深入分析。本综述将重点介绍自下而上的蛋白质组学在表转录组学领域的应用,特别是在表转录组读取、书写和擦除(RWE)蛋白的鉴定和定量方面,以及在表征其功能、翻译后修饰以及与其他蛋白的相互作用方面。通过利用现代蛋白质组学,研究人员可以深入了解 RNA 修饰错综复杂的调控网络,从而推动基础生物学的发展,并促进潜在的治疗应用。
{"title":"Mass Spectrometry-Based Proteomics for Assessing Epitranscriptomic Regulations","authors":"Yen-Yu Yang,&nbsp;Zhongwen Cao,&nbsp;Yinsheng Wang","doi":"10.1002/mas.21911","DOIUrl":"10.1002/mas.21911","url":null,"abstract":"<div>\u0000 \u0000 <p>Epitranscriptomics is a rapidly evolving field that explores chemical modifications in RNA and how they contribute to dynamic and reversible regulations of gene expression. These modifications, for example, <i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A), are crucial in various RNA metabolic processes, including splicing, stability, subcellular localization, and translation efficiency of mRNAs. Mass spectrometry-based proteomics has become an indispensable tool in unraveling the complexities of epitranscriptomics, offering high-throughput, precise protein identification, and accurate quantification of differential protein expression. Over the past two decades, advances in mass spectrometry, including the improvement of high-resolution mass spectrometers and innovative sample preparation methods, have allowed researchers to perform in-depth analyses of epitranscriptomic regulations. This review focuses on the applications of bottom-up proteomics in the field of epitranscriptomics, particularly in identifying and quantifying epitranscriptomic reader, writer, and eraser (RWE) proteins and in characterizing their functions, posttranslational modifications, and interactions with other proteins. Together, by leveraging modern proteomics, researchers can gain deep insights into the intricate regulatory networks of RNA modifications, advancing fundamental biology, and fostering potential therapeutic applications.</p>\u0000 </div>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"672-690"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142454325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in Mass Spectrometry-Based Glycomics in Food and Nutritional Science 食品与营养科学中基于质谱的糖组学研究进展。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2025-08-01 DOI: 10.1002/mas.70003
JaeHui Song, HyunJi Lee, Youngshik Choe, Hyeyoung Lee

This review highlights advancements in mass spectrometry (MS)-based glycomics in food and nutritional science. Carbohydrates, which are vital for human health, exhibit complex structures, making their analysis challenging. MS has become an indispensable tool for elucidating the structures of carbohydrates, including glycans, through soft ionization techniques such as MALDI and ESI. Furthermore, coupling MS with advanced separation techniques enhances sensitivity and resolution. This review underscores the pivotal contributions of Professor Carlito B. Lebrilla to glycomics research, particularly regarding milk oligosaccharides and dietary fibers, and their roles in gut health. Comprehensive food glycomic databases and MS-based studies offer valuable insights into the functions of carbohydrates and their implications for nutrition.

本文综述了基于质谱(MS)的糖组学在食品和营养科学中的进展。碳水化合物对人类健康至关重要,其结构复杂,使其分析具有挑战性。质谱已成为通过软电离技术(如MALDI和ESI)阐明包括聚糖在内的碳水化合物结构的不可或缺的工具。此外,将质谱与先进的分离技术相结合,提高了灵敏度和分辨率。这篇综述强调了Carlito B. Lebrilla教授对糖组学研究的关键贡献,特别是在牛奶低聚糖和膳食纤维及其在肠道健康中的作用方面。全面的食物糖糖数据库和基于质谱的研究为碳水化合物的功能及其对营养的影响提供了有价值的见解。
{"title":"Advancements in Mass Spectrometry-Based Glycomics in Food and Nutritional Science","authors":"JaeHui Song,&nbsp;HyunJi Lee,&nbsp;Youngshik Choe,&nbsp;Hyeyoung Lee","doi":"10.1002/mas.70003","DOIUrl":"10.1002/mas.70003","url":null,"abstract":"<p>This review highlights advancements in mass spectrometry (MS)-based glycomics in food and nutritional science. Carbohydrates, which are vital for human health, exhibit complex structures, making their analysis challenging. MS has become an indispensable tool for elucidating the structures of carbohydrates, including glycans, through soft ionization techniques such as MALDI and ESI. Furthermore, coupling MS with advanced separation techniques enhances sensitivity and resolution. This review underscores the pivotal contributions of Professor Carlito B. Lebrilla to glycomics research, particularly regarding milk oligosaccharides and dietary fibers, and their roles in gut health. Comprehensive food glycomic databases and MS-based studies offer valuable insights into the functions of carbohydrates and their implications for nutrition.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"829-850"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mas.70003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carlito B. Lebrilla: Building Instruments, Fields and Opportunities From the Ground up Carlito B. Lebrilla:从头开始构建工具、领域和机会。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2026-05-15 DOI: 10.1002/mas.70032
Benjamin A. Garcia
{"title":"Carlito B. Lebrilla: Building Instruments, Fields and Opportunities From the Ground up","authors":"Benjamin A. Garcia","doi":"10.1002/mas.70032","DOIUrl":"10.1002/mas.70032","url":null,"abstract":"","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"591-596"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147947323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometry-Based Proteomics Technologies to Define Endogenous Protein-Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases 基于质谱的蛋白质组学技术定义内源性蛋白质-蛋白质相互作用及其在癌症和病毒性传染病中的应用。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2025-02-09 DOI: 10.1002/mas.21926
Clinton Yu, Rithika Adavikolanu, Robyn M. Kaake, Lan Huang

An intricate network of protein assemblies and protein-protein interactions (PPIs) underlies nearly every biological process in living systems. The organization of these cellular networks is highly dynamic and intimately tied to the genomic and proteomic landscapes of a cell. Disruptions in normal PPIs can impair cellular functions and contribute to the development of human diseases. In recent years, targeting PPIs has emerged as an attractive strategy for drug discovery. Consequently, the identification and characterization of endogenous PPIs—those occurring naturally under physiological conditions—has become crucial for unraveling the molecular mechanisms driving human pathology and for laying the groundwork for novel diagnostics and therapeutics. Owing to numerous technological advancements, mass spectrometry (MS)-based proteomics has transformed the study of PPIs at the systems-level. This review focuses on proteomics approaches that enable the characterization of physiologically relevant endogenous interactions, spanning complex-centric to structure-centric analyses. Additionally, their applications to define native PPIs in the contexts of cancer and viral infectious diseases is highlighted.

蛋白质组装和蛋白质-蛋白质相互作用(PPIs)的复杂网络是生命系统中几乎所有生物过程的基础。这些细胞网络的组织是高度动态的,与细胞的基因组和蛋白质组学景观密切相关。正常PPIs的破坏可损害细胞功能并促进人类疾病的发展。近年来,靶向PPIs已成为一种有吸引力的药物发现策略。因此,内源性ppis(在生理条件下自然发生的ppis)的鉴定和表征对于揭示驱动人类病理的分子机制以及为新型诊断和治疗奠定基础至关重要。由于许多技术的进步,基于质谱(MS)的蛋白质组学已经在系统水平上改变了ppi的研究。这篇综述的重点是蛋白质组学方法,使生理相关的内源性相互作用的表征,跨越复杂中心到结构中心的分析。此外,强调了它们在癌症和病毒性传染病背景下定义原生PPIs的应用。
{"title":"Mass Spectrometry-Based Proteomics Technologies to Define Endogenous Protein-Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases","authors":"Clinton Yu,&nbsp;Rithika Adavikolanu,&nbsp;Robyn M. Kaake,&nbsp;Lan Huang","doi":"10.1002/mas.21926","DOIUrl":"10.1002/mas.21926","url":null,"abstract":"<div>\u0000 \u0000 <p>An intricate network of protein assemblies and protein-protein interactions (PPIs) underlies nearly every biological process in living systems. The organization of these cellular networks is highly dynamic and intimately tied to the genomic and proteomic landscapes of a cell. Disruptions in normal PPIs can impair cellular functions and contribute to the development of human diseases. In recent years, targeting PPIs has emerged as an attractive strategy for drug discovery. Consequently, the identification and characterization of endogenous PPIs—those occurring naturally under physiological conditions—has become crucial for unraveling the molecular mechanisms driving human pathology and for laying the groundwork for novel diagnostics and therapeutics. Owing to numerous technological advancements, mass spectrometry (MS)-based proteomics has transformed the study of PPIs at the systems-level. This review focuses on proteomics approaches that enable the characterization of physiologically relevant endogenous interactions, spanning complex-centric to structure-centric analyses. Additionally, their applications to define native PPIs in the contexts of cancer and viral infectious diseases is highlighted.</p>\u0000 </div>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"714-744"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143381386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MS-Based Glycome Characterization of Biotherapeutics With N- and O-Glycosylation 基于质谱的N-和o -糖基化生物治疗药物的糖化表征。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2025-01-27 DOI: 10.1002/mas.21925
Myung Jin Oh, Youngsuk Seo, Nari Seo, Hyun Joo An

With the increasing FDA approvals of glycoprotein-based biotherapeutics including monoclonal antibodies, cytokines, and enzyme treatments, the significance of glycosylation in modulating drug efficacy and safety becomes central. This review highlights the crucial role of mass spectrometry (MS) in elucidating the glycome of biotherapeutics that feature N- and O-glycosylation, directly addressing the challenges posed by glycosylation complexity and heterogeneity. We have detailed the advancements and application of MS technologies including MALDI-TOF MS, LC-MS, and tandem MS in the precise characterization of glycoprotein therapeutics. Emphasizing MS-based strategies for detecting immunogenic glycans and ensuring batch-to-batch consistency, this review highlights targeted approaches for glycoprotein, glycopeptide, and glycan analysis tailored to meet the stringent analytical and regulatory demands of biopharmaceutical development.

随着越来越多基于糖蛋白的生物治疗药物(包括单克隆抗体、细胞因子和酶疗法)获得美国食品与药物管理局(FDA)的批准,糖基化在调节药物疗效和安全性方面的意义变得至关重要。本综述强调了质谱(MS)在阐明以 N- 和 O- 糖基化为特征的生物治疗药物的糖基化结果中的关键作用,直接解决了糖基化复杂性和异质性带来的挑战。我们详细介绍了 MS 技术(包括 MALDI-TOF MS、LC-MS 和串联 MS)在精确表征糖蛋白治疗药物方面的进步和应用。本综述强调了基于 MS 的免疫原性聚糖检测策略,并确保批次间的一致性,重点介绍了糖蛋白、糖肽和聚糖分析的针对性方法,以满足生物制药开发过程中严格的分析和监管要求。
{"title":"MS-Based Glycome Characterization of Biotherapeutics With N- and O-Glycosylation","authors":"Myung Jin Oh,&nbsp;Youngsuk Seo,&nbsp;Nari Seo,&nbsp;Hyun Joo An","doi":"10.1002/mas.21925","DOIUrl":"10.1002/mas.21925","url":null,"abstract":"<div>\u0000 \u0000 <p>With the increasing FDA approvals of glycoprotein-based biotherapeutics including monoclonal antibodies, cytokines, and enzyme treatments, the significance of glycosylation in modulating drug efficacy and safety becomes central. This review highlights the crucial role of mass spectrometry (MS) in elucidating the glycome of biotherapeutics that feature N- and O-glycosylation, directly addressing the challenges posed by glycosylation complexity and heterogeneity. We have detailed the advancements and application of MS technologies including MALDI-TOF MS, LC-MS, and tandem MS in the precise characterization of glycoprotein therapeutics. Emphasizing MS-based strategies for detecting immunogenic glycans and ensuring batch-to-batch consistency, this review highlights targeted approaches for glycoprotein, glycopeptide, and glycan analysis tailored to meet the stringent analytical and regulatory demands of biopharmaceutical development.</p>\u0000 </div>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"691-713"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometry Structural Proteomics Enabled by Limited Proteolysis and Cross-Linking 通过有限蛋白质分解和交联实现质谱结构蛋白质组学。
IF 6.6 2区 化学 Q1 SPECTROSCOPY Pub Date : 2026-06-07 Epub Date: 2024-09-19 DOI: 10.1002/mas.21908
Haiyan Lu, Zexin Zhu, Lauren Fields, Hua Zhang, Lingjun Li

The exploration of protein structure and function stands at the forefront of life science and represents an ever-expanding focus in the development of proteomics. As mass spectrometry (MS) offers readout of protein conformational changes at both the protein and peptide levels, MS-based structural proteomics is making significant strides in the realms of structural and molecular biology, complementing traditional structural biology techniques. This review focuses on two powerful MS-based techniques for peptide-level readout, namely limited proteolysis-mass spectrometry (LiP-MS) and cross-linking mass spectrometry (XL-MS). First, we discuss the principles, features, and different workflows of these two methods. Subsequently, we delve into the bioinformatics strategies and software tools used for interpreting data associated with these protein conformation readouts and how the data can be integrated with other computational tools. Furthermore, we provide a comprehensive summary of the noteworthy applications of LiP-MS and XL-MS in diverse areas including neurodegenerative diseases, interactome studies, membrane proteins, and artificial intelligence-based structural analysis. Finally, we discuss the factors that modulate protein conformational changes. We also highlight the remaining challenges in understanding the intricacies of protein conformational changes by LiP-MS and XL-MS technologies.

对蛋白质结构和功能的探索是生命科学的前沿,也是蛋白质组学发展中不断扩展的重点。由于质谱(MS)可在蛋白质和肽水平读出蛋白质的构象变化,因此基于质谱的结构蛋白质组学在结构和分子生物学领域取得了重大进展,是对传统结构生物学技术的补充。本综述重点介绍两种强大的基于质谱的肽水平读出技术,即有限蛋白水解质谱(LiP-MS)和交联质谱(XL-MS)。首先,我们将讨论这两种方法的原理、特点和不同的工作流程。随后,我们深入探讨了用于解释这些蛋白质构象读数相关数据的生物信息学策略和软件工具,以及如何将这些数据与其他计算工具整合。此外,我们还全面总结了 LiP-MS 和 XL-MS 在神经退行性疾病、相互作用组研究、膜蛋白和基于人工智能的结构分析等不同领域中值得关注的应用。最后,我们讨论了调节蛋白质构象变化的因素。我们还强调了利用 LiP-MS 和 XL-MS 技术了解蛋白质构象变化的复杂性所面临的挑战。
{"title":"Mass Spectrometry Structural Proteomics Enabled by Limited Proteolysis and Cross-Linking","authors":"Haiyan Lu,&nbsp;Zexin Zhu,&nbsp;Lauren Fields,&nbsp;Hua Zhang,&nbsp;Lingjun Li","doi":"10.1002/mas.21908","DOIUrl":"10.1002/mas.21908","url":null,"abstract":"<p>The exploration of protein structure and function stands at the forefront of life science and represents an ever-expanding focus in the development of proteomics. As mass spectrometry (MS) offers readout of protein conformational changes at both the protein and peptide levels, MS-based structural proteomics is making significant strides in the realms of structural and molecular biology, complementing traditional structural biology techniques. This review focuses on two powerful MS-based techniques for peptide-level readout, namely limited proteolysis-mass spectrometry (LiP-MS) and cross-linking mass spectrometry (XL-MS). First, we discuss the principles, features, and different workflows of these two methods. Subsequently, we delve into the bioinformatics strategies and software tools used for interpreting data associated with these protein conformation readouts and how the data can be integrated with other computational tools. Furthermore, we provide a comprehensive summary of the noteworthy applications of LiP-MS and XL-MS in diverse areas including neurodegenerative diseases, interactome studies, membrane proteins, and artificial intelligence-based structural analysis. Finally, we discuss the factors that modulate protein conformational changes. We also highlight the remaining challenges in understanding the intricacies of protein conformational changes by LiP-MS and XL-MS technologies.</p>","PeriodicalId":206,"journal":{"name":"Mass Spectrometry Reviews","volume":"45 4","pages":"644-671"},"PeriodicalIF":6.6,"publicationDate":"2026-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mas.21908","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mass Spectrometry Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1